Fig. 7
Effects of optogenetic manipulation of VPL or its terminals. Schematic representation of the infection and stimulation sites (a, e top). Histological confirmation of viral expression and optical fiber positions in the VPL and DLS (a, e, middle). Schematic representation of the moment when the stimulation was delivered during 50% of the randomly selected trials (a, e, bottom). b, f Entrance times for all stimulated (yellow for Halorhodopsin or Archaerhodopsin; blue for Channelrhodopsin-2) vs. nonstimulated (black) trials; box plots indicate the median (25th and 75th percentiles) of the stimulated vs. nonstimulated trials; pairs of dots united by lines indicate medians of each session for each animal; the number of trials analyzed for each animal and condition is indicated at the bottom. c, g Percentage of correct trials for one animal on each group. d, h Average position (top) and speed (bottom) trajectories for all stimulated and non-stimulated trials of Rat F (d) and Rat A (h). **Wilcoxon rank-sum test p < 0.001
